Novo Nordisk relocates data management from Singapore to India

By Kirsty Barnes

- Last updated on GMT

Related tags Data management

Novo Nordisk is in the process of relocating its clinical data
management centre to India after closing down the operation in
Singapore, where it had been previously run for many years.

The company's data management exit from Singapore was due to the closing of its clinical development centre in the country, which has now moved to Beijing, on the heels of the head of the team who wanted to make the move. "Now that we no longer have a clinical development centre in Singapore we decided to move the data management function to India where we feel there is more experience in this field,"​ company spokesperson Anne Prener told The Danish biopharma giant already has an office in Bangalore, where the centre will now be located. Until now the firm only had sales and marketing staff located at this site, along with a small team conducting data management for local clinical trials. "We are currently running a number of trials in India,"​ said Prener. Soon, however, data management for Novo's global trials from 60 countries across the Asia-Pacific (excluding Japan), Africa and Latin America will be done from this new location. Recruitment is underway now for around 20 new staff at the site, as the company's data management employees at the former site in Singapore did not relocate. At this point, the company has no further expansion plans in India, said Prener. Meanwhile, Novo's existing relationship with Indian IT service firm Tata Consultancy Services (TCS) remains unchanged, she said. TCS has been working with the company in India for a number of years assisting the company with the data management of its clinical trials run in India, on an "overflow basis."​ Novo Nordisk is one of a growing number of biopharma firms who have been actively implementing an outsourcing strategy as a cost-cutting and time saving measure and also has number of other such agreements in place in India.

Related news

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more